(Alliance News) - Stock prices in London closed higher on Friday, with markets maintaining the optimism that prevailed after US President Donald Trump said on Wednesday that it was "highly unlikely" that he would fire Federal Reserve Chair Jerome Powell. Read More
(Alliance News) - Stock prices in Europe were largely higher at midday on Friday, though the FTSE 100 pared some earlier gains as a slump from GSK weighed on the index. Read More
(Alliance News) - Stock prices in Europe opened higher early on Friday, with the FTSE 100 almost hitting a new record high, as a swathe of dealmaking was well-received in London. Read More
(Alliance News) - GSK PLC on Thursday noted that the US Food & Drug Administration Oncologic Drugs Advisory Committee voted against the overall benefit/risk profile at the proposed dosage of Blenrep combinations. Read More
(Alliance News) - GSK PLC on Thursday said the prefilled syringe version of its vaccine Shingrix has been approved for use in the US for the prevention of shingles. Read More
(Alliance News) - GSK PLC on Monday said it has submitted a US regulatory application for the expanded use of its Arexvy respiratory syncytial virus vaccine. Read More
(Alliance News) - DCC announced a deal to sell a part of its technology arm for GBP100 million, GSK is pursuing US approval for expanded use of its RSV jab, while South32 warned of an impairment at an aluminium smelter in Mozambique. Read More
(Alliance News) - London's FTSE 100 closed a winning week on the back foot after soft economic growth figures and threats of further tariffs from the US. Read More
(Alliance News) - Stock prices in Europe opened in the green on Wednesday, shaking off a more stern tone from US President Donald Trump on trade policy, though the threat of sector tariffs on copper and pharmaceuticals hit miners and drug makers. Read More
(Alliance News) - The FTSE 100 and sterling rallied, while the bond market calmed on Thursday as Keir Starmer supported his chancellor, reassuring markets that a change at the Treasury wasn't on the cards. Read More
(Alliance News) - GSK PLC on Monday said linerixibat has been accepted for review by the European Medicines Agency for the treatment of intense itching caused by a rare autoimmune liver disease. Read More
(Alliance News) - London's FTSE 100 faded into the close on Friday, ending lower, as weak retail sales data and falls in heavyweight oil and drug stocks offset hopes for progress in the Israel-Iran conflict. Read More
(Alliance News) - GSK PLC on Friday announced that Japan has accepted a regulatory application to expand the use of its respiratory syncytial virus [RSV] vaccine Arexvy. Read More
(Alliance News) - London's FTSE 100 posted modest gains on Wednesday amid ongoing Middle East tensions, as investors weighed broadly in line UK inflation data ahead of rate calls on either side of the pond. Read More
(Alliance News) - The following is a round-up of share dealings by London-listed company directors and managers announced in the past several days and not separately reported by Alliance News: Read More
(Alliance News) - The FTSE 100 ended higher on Monday, just shy of a record closing high, on reports Iran is willing to resume nuclear talks with the US. Read More
